BioSpace News Archive

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), today announced that it has entered into an expanded global, non-exclusive license and collaboration agreement with GSK plc (LSE/NYSE: GSK) for nirogacestat, SpringWorks’ investigational oral gamma secretase inhibitor, in combination with Blenrep (belantamab mafodotin-blmf), GSK’s antibody-drug conjugate targeting B-cell maturation antigen (BCMA).

SpringWorks Therapeutics, Inc. announced that it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 8,625,520 shares of its common stock at a price per share of $26.01 in a private placement transaction.

Brainomix, the AI-powered medtech solutions company, and Bridge Biotherapeutics, Inc., a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, today announced a new partnership to deliver quantitative imaging biomarker analysis within the Phase 2 study of novel autotaxin inhibitor BBT-877, which has been designed to evaluate the safety, tolerability and efficacy of BBT-877 in Idiopathic Pulmonary Fibrosis (IPF).

CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) (“CVR Medical” or the “Company” or “we”) a Canadian listed and US based healthcare company in the medical device market is pleased to announce the completion and filing of its 2022 Q2 Financial Statement.

Nelipak Corporation announced it has received International Sustainability and Carbon Certification PLUS certificates at two of its North American facilities.

Monteris Medical announced today that the first patient has been enrolled in its REMASTer (Recurrent Brain Metastases After Stereotactic Radiosurgery [SRS] Trial) clinical trial.

Agadia Systems, Inc. (Agadia), a recognized healthcare technology solution provider for over 50 of the nation’s leading Health Plans & PBMs, is announcing an integration with language solutions provider, CQ fluency, to provide translation services within Agadia’s prior authorization solution, PAHub.

Molecular Stethoscope, announced publication of the study entitled “Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice” in eBiomedicine, part of Lancet Discovery Science, a leading biomedical journal, that bridges the translational gap between basic and clinical research.

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on developing lenzilumab (“LENZ®"), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (“GM-CSF”), today announced presentation and participation in two healthcare focused investor conferences in September 2022.

Clinical trials are a traditional ways to determine the safety and efficiency of a drug or a medical device, or any other therapeutic product.